Litcius/Paper detail

PD-L1 expression and Tumor mutation burden as Pathological response biomarkers of Neoadjuvant immunotherapy for Early-stage Non-small cell lung cancer: A systematic review and meta-analysis

Hongsheng Deng, Yi Zhao, Xiuyu Cai, Hualin Chen, Bo Cheng, Ran Zhong, Feng Li, Shan Xiong, Jianfu Li, Jun Liu, Jianxing He, Wenhua Liang

2022Critical Reviews in Oncology/Hematology107 citationsDOI

Topics & Concepts

MedicineOncologyImmunotherapyPathologicalLung cancerInternal medicineNeoadjuvant therapyStage (stratigraphy)Meta-analysisOdds ratioConfidence intervalBiomarkerCancerChemotherapyBiologyBreast cancerBiochemistryPaleontologyCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsColorectal and Anal Carcinomas
PD-L1 expression and Tumor mutation burden as Pathological response biomarkers of Neoadjuvant immunotherapy for Early-stage Non-small cell lung cancer: A systematic review and meta-analysis | Litcius